Cover Image

The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII

Human (h) carbonic anhydrase (CAs, EC 4.2.1.1) isoforms IX and XII were recently confirmed as anticancer targets against solid hypoxic tumours. The "three-tails approach" has been proposed as an extension of the forerunner "tail" and "dual-tail approach" to fully exploi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessandro Bonardi (Author), Silvia Bua (Author), Jacob Combs (Author), Carrie Lomelino (Author), Jacob Andring (Author), Sameh Mohamed Osman (Author), Alessandra Toti (Author), Lorenzo Di Cesare Mannelli (Author), Paola Gratteri (Author), Carla Ghelardini (Author), Robert McKenna (Author), Alessio Nocentini (Author), Claudiu T. Supuran (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics study
by: Alessandro Bonardi, et al.
Published: (2021)

Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase
by: Linda J. Urbanski, et al.
Published: (2020)

Escherichia coli γ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors
by: Sonia Del Prete, et al.
Published: (2020)

Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors
by: Simone Giovannuzzi, et al.
Published: (2023)

Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives
by: Deepak Shilkar, et al.
Published: (2023)

Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
by: Ismail Koyuncu, et al.
Published: (2019)

Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
by: Alessandra Rogato, et al.
Published: (2019)

Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
by: Mohamed A. Abdelrahman, et al.
Published: (2020)

Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms
by: Alessio Nocentini, et al.
Published: (2018)

Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
by: Fadi M. Awadallah, et al.
Published: (2018)

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
by: Nader S. Abutaleb, et al.
Published: (2022)

The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action
by: Mehmet Oguz, et al.
Published: (2020)

Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines
by: Silvia Mussi, et al.
Published: (2022)

Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite Gyrodactylus salaris
by: Ashok Aspatwar, et al.
Published: (2023)

Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide-hydantoin hybrids
by: Morteza Abdoli, et al.
Published: (2024)

Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors
by: Özlen Güzel-Akdemir, et al.
Published: (2018)

Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
by: Daniela Vullo, et al.
Published: (2018)

Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides
by: Linda J. Urbański, et al.
Published: (2021)

Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis β-class enzyme Rv3273
by: Tanvi V. Wani, et al.
Published: (2018)

Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties
by: Kalyan K. Sethi, et al.
Published: (2021)

Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
by: Nora Astrain-Redin, et al.
Published: (2023)

Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species
by: Verônica da Silva Cardoso, et al.
Published: (2018)

Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
by: Mehmet Onyılmaz, et al.
Published: (2022)

Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells
by: Ismail Koyuncu, et al.
Published: (2018)

Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry
by: Marta Menicatti, et al.
Published: (2018)

Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties
by: Sinan Bilginer, et al.
Published: (2020)

Diversely N-substituted benzenesulfonamides dissimilarly bind to human carbonic anhydrases: crystallographic investigations of N-nitrosulfonamides
by: Andrea Angeli, et al.
Published: (2023)

Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides
by: Simona Maria Monti, et al.
Published: (2018)

Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid-sulphonamide conjugates
by: Hasan Küçükbay, et al.
Published: (2020)

Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors
by: Suleyman Akocak, et al.
Published: (2018)

The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX
by: Zainab Saad Yusuf, et al.
Published: (2022)

An overview on the recently discovered iota-carbonic anhydrases
by: Alessio Nocentini, et al.
Published: (2021)

Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives
by: Murat Bozdag, et al.
Published: (2017)

Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies
by: Emma Baglini, et al.
Published: (2021)

Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation
by: Paolo Guglielmi, et al.
Published: (2020)

Effect of hydrophobic extension of aryl enaminones and pyrazole-linked compounds combined with sulphonamide, sulfaguanidine, or carboxylic acid functionalities on carbonic anhydrase inhibitory potency and selectivity
by: Heba Abdelrasheed Allam, et al.
Published: (2023)

Protective effects of carbonic anhydrase inhibition in brain ischaemia in vitro and in vivo models
by: Ilaria Dettori, et al.
Published: (2021)

3H-1,2-Benzoxaphosphepine 2-oxides as selective inhibitors of carbonic anhydrase IX and XII
by: Aleksandrs Pustenko, et al.
Published: (2023)

Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives
by: Suleyman Akocak, et al.
Published: (2019)